Early-stage focus Notation Capital concentrates on very early-stage technical teams, often pre-market or pre-product, primarily in New York. This presents outreach opportunities to portfolio founders and potential deal flow in seed and pre-seed rounds, especially for engineers and technical co-founders seeking early capital and go-to-market support.

Brooklyn roots As a Brooklyn-based fund with a small team (2-10 employees), Notation Capital can be approached as a relationship-driven partner for local startups, accelerators, and co-investors looking to collaborate on first-check investments and portfolio value-add in the NYC tech ecosystem.

Notable exits Participation in recent rounds for companies like QA Wolf and Wayfinder Biosciences demonstrates a track record of backing diverse tech ventures. This signals potential for follow-on rounds, cross-portfolio introductions, and syndication opportunities with other investors that have invested alongside Notation.

Cloud and dev tools Notation’s portfolio and tech-adjacent interests include cloud infrastructure, software testing platforms, and QA tooling (evidenced by investments and tech stack mentions). Reach out to teams building infrastructure, testing, or developer experience tools that align with Notation’s focus areas for potential collaboration or co-investment.

Portfolio expansion cues Recent investments span bio and software sectors, suggesting openness to cross-industry opportunities and strategic partnerships. Sales outreach could target portfolio companies in RNA design, biosciences, and cloud-based SaaS, highlighting synergies in early-stage funding, go-to-market support, and technical mentorship.